Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Fella Health vs LillyDirect Foundayo

Fella Health
Graded #248

Lower grade

vs+3.200000000000003
LillyDirect Foundayo
Graded #173

Higher grade

The verdict

LillyDirect Foundayo takes it — 67.2/100 to 64/100.

LillyDirect Foundayo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLillyDirect Foundayo +30
42
72
Dose & formulationFella Health +5
64
59
Clinical oversightFella Health +11
89
78
Labs & monitoringFella Health +11
63
52
FulfillmentLillyDirect Foundayo +5
75
80
Contract termsEven
55
55
Fella Health · left barLillyDirect Foundayo · right bar

The numbers

MetricFella HealthLillyDirect Foundayo
WeighScore64/10067.2/100
GradeCC
Scorecard rank#248#173
Semaglutide$299/mo (compounded)Not disclosed
Tirzepatide$449/mo (compounded)Not disclosed
Coverage20 statesAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Fella Health

Graded #248 · C

Strengths

  • Specialized vertical — program designed for men, particularly 'bigger guys'
  • Free 1:1 health coaching included with the membership
  • 6-month money-back guarantee if the program doesn't work
  • Flat monthly price stays the same as your dose escalates
  • Both compounded semaglutide and tirzepatide available

Where it loses points

  • Limited to men's health vertical — not available to women
  • Available in only 20 published states (not nationwide)
  • Exact GLP-1 monthly cost not published on the public site — only an 'under $10/day' starting figure
  • Pricing transparency below industry standard for compounded GLP-1 telehealth
LillyDirect Foundayo

Graded #173 · C

Strengths

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Where it loses points

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard